Chronic Kidney Disease News

CHICAGO — A radiofrequency renal denervation system lowered BP in patients with resistant hypertension already on antihypertensive medication at 6 months, but did not meet its primary efficacy endpoint.

ORLANDO — In this video from ASN Kidney Week, Abdul A. Abdellatif, MD, discusses the efficacy of pegloticase treatment in conjunction with methotrexate for patients with uncontrolled gout.

ORLANDO — In this video from ASN Kidney Week, Samir V. Parikh, MD, discusses the results of the AURORA 2 study.

ORLANDO — Isuzinaxib, a pan-NOX inhibitor modulating oxidative stress by Aptabio significantly reduced urine albumin-to-creatinine ratio in patients with type 2 diabetes and chronic kidney disease, according to data at ASN Kidney Week.

ORLANDO — In this video from ASN Kidney Week, Jonathan Barratt, MBChB, PhD, discusses Calliditas Therapeutics’ Tarpeyo treatment, previously known as Nefecon, for patients with IgA nephropathy.

ORLANDO — In Black adults with hypertension and chronic kidney disease, coaching about purchasing food with high potassium improved diet quality and albuminuria, according to a presenter at ASN Kidney Week.

In this video from ASN Kidney Week, Navdeep Tangri, MD, PhD, discusses the results of the REVEAL CKD study.

CHICAGO — A meta-analysis of 13 large SGLT2 inhibitor trials, including the recently published EMPA-KIDNEY trial, indicates that the drug class reduces CV and renal outcomes across all high-risk groups, with and without type 2 diabetes.

ORLANDO — A patient’s social determinants of health will influence access to chronic kidney disease screening and diagnosis and treatment of CKD, researchers reported here.

ORLANDO — In this video from ASN Kidney Week, Mike Spigler, shared the results of a survey connected to the Unknown Causes of Kidney Disease Project regarding genetic testing for chronic kidney disease.